• 1. An investigation into the origin of variations in photovoltaic performance using D–D–π–A and D–A–π–A triphenylimidazole dyes with a copper electrolyte?
  Govind Reddy Mol. Syst. Des. Eng., 2021,6, 779-789
• 2. Aluminium complexes with thio-phosphorus ligands: syntheses and characterisations of [Al2(CyPS3)2(CyPHS2)2] and [Al(S2PPh2)3]?
  Robert P. Davies,Maria A. Giménez,Laura Patel,Andrew J. P. White Dalton Trans., 2008, 5705-5707
• 3. An artificial photosynthesis system comprising a covalent triazine framework as an electron relay facilitator for photochemical carbon dioxide reduction?
  Siquan Zhang,Shengyao Wang,Liping Guo,Hao Chen,Bien Tan,Shangbin Jin J. Mater. Chem. C, 2020,8, 192-200
• 4. An investigation of new infrared nonlinear optical material: BaCdSnSe4, and three new related centrosymmetric compounds: Ba2SnSe4, Mg2GeSe4, and Ba2Ge2S6?
  Kui Wu,Zhihua Yang,Shilie Pan Dalton Trans., 2015,44, 19856-19864
• 5. An anti-leakage liquid metal thermal interface material
  Kaiyuan Huang,Wangkang Qiu,Meilian Ou,Xiaorui Liu,Zenan Liao,Sheng Chu RSC Adv., 2020,10, 18824-18829

• Solvents and Organic Chemicals Organic Compounds Phenylpropanoids and polyketides Flavonoids Catechin gallates

Tea Polyphenol (84650-60-2): Chemical Structure and Biological Significance

Tea polyphenol, with the CAS number 84650-60-2, is a bioactive compound derived from Camellia sinensis (tea plant). Its molecular structure is characterized by multiple phenolic hydroxyl groups, which contribute to its potent antioxidant properties. In recent years, research has focused on its role in modulating oxidative stress, inflammation, and metabolic disorders. Studies indicate that tea polyphenol (84650-60-2) can scavenge free radicals, inhibit lipid peroxidation, and regulate signaling pathways such as NF-κB and Nrf2. These mechanisms make it a promising candidate for neurodegenerative disease prevention and cardiovascular health, topics highly searched by health-conscious users.

84650-60-2 Tea Polyphenol in Cancer Research and Therapeutics

The anticancer potential of tea polyphenol (84650-60-2) has garnered significant attention in pharmacological research. Its ability to induce apoptosis, suppress angiogenesis, and inhibit metastasis has been validated in preclinical models. For instance, epigallocatechin gallate (EGCG), a major component of tea polyphenol, demonstrates chemopreventive effects against breast, prostate, and colorectal cancers. Users searching for natural anticancer agents often explore its synergy with conventional therapies. Recent clinical trials highlight its role in enhancing chemotherapy efficacy while reducing side effects, aligning with the growing demand for integrative oncology approaches.

Tea Polyphenol (84650-60-2) and Metabolic Syndrome Management

With rising global rates of obesity and diabetes, tea polyphenol (84650-60-2) is increasingly studied for its anti-diabetic and anti-obesity properties. Research shows it enhances insulin sensitivity, inhibits adipogenesis, and promotes lipid metabolism via AMPK activation. These findings resonate with users seeking natural weight loss supplements or blood sugar regulators. A 2023 meta-analysis revealed that daily intake of tea polyphenols significantly lowers fasting glucose and LDL cholesterol, making it a trending topic in functional food and nutraceutical discussions.

84650-60-2 Tea Polyphenol: Safety and Dosage Recommendations

Consumer queries often focus on the safety profile and optimal dosage of tea polyphenol (84650-60-2). Toxicology studies confirm its low toxicity, with adverse effects (e.g., hepatotoxicity) only observed at extremely high doses. Regulatory agencies recommend a daily intake of 300–400 mg for antioxidant benefits, while therapeutic applications may require higher doses under medical supervision. This segment addresses frequent user concerns about supplement interactions and long-term use, ensuring alignment with evidence-based guidelines.

Future Prospects of 84650-60-2 Tea Polyphenol in Personalized Medicine

The integration of tea polyphenol (84650-60-2) into precision medicine is an emerging frontier. Advances in omics technologies (e.g., metabolomics) enable researchers to identify biomarkers predicting individual responses to tea polyphenol interventions. This aligns with user interest in tailored health solutions and genetic-based nutrition. Collaborative efforts between academia and industry aim to develop standardized extracts and delivery systems (e.g., nanoparticles), further enhancing bioavailability and therapeutic efficacy for conditions like aging-related diseases.

• 1401-55-4(Tannic acid)
• 9002-13-5(Urease)
• 9025-71-2(Tannase)
• 149-91-7(Gallic acid)
• 9001-62-1(Triacylglycerol lipase)
• 121-79-9(Propyl gallate)
• 110-15-6(butanedioic acid)
• 99-24-1(Methyl gallate)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)